CRIS Current Research Information System

GRAZI, GIAN LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.723
AS - Asia 13.012
EU - Europa 9.624
AF - Africa 801
SA - Sud America 781
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 39.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.585
VN - Vietnam 3.623
SG - Singapore 3.535
CN - Cina 3.164
GB - Regno Unito 2.623
DE - Germania 1.388
IT - Italia 1.094
SE - Svezia 1.090
HK - Hong Kong 878
FR - Francia 741
IN - India 741
UA - Ucraina 642
BR - Brasile 566
RU - Federazione Russa 561
IE - Irlanda 357
JP - Giappone 238
NL - Olanda 237
ZA - Sudafrica 235
FI - Finlandia 214
EE - Estonia 195
TG - Togo 180
CI - Costa d'Avorio 169
KR - Corea 165
CH - Svizzera 125
SC - Seychelles 100
AR - Argentina 96
CA - Canada 82
JO - Giordania 82
BG - Bulgaria 80
PH - Filippine 76
TH - Thailandia 69
BD - Bangladesh 67
IQ - Iraq 53
BE - Belgio 48
ID - Indonesia 42
NG - Nigeria 41
IR - Iran 38
ES - Italia 36
PL - Polonia 36
MX - Messico 34
AT - Austria 33
PK - Pakistan 33
EC - Ecuador 31
TR - Turchia 30
GR - Grecia 28
UZ - Uzbekistan 24
CO - Colombia 22
RO - Romania 22
MY - Malesia 20
CL - Cile 19
SA - Arabia Saudita 19
TW - Taiwan 19
IL - Israele 16
LB - Libano 16
HR - Croazia 15
PE - Perù 15
AU - Australia 14
TN - Tunisia 14
MA - Marocco 12
VE - Venezuela 12
EG - Egitto 11
KE - Kenya 10
PY - Paraguay 9
NP - Nepal 8
PS - Palestinian Territory 8
DK - Danimarca 7
KH - Cambogia 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
ET - Etiopia 6
EU - Europa 6
AZ - Azerbaigian 5
CR - Costa Rica 5
HU - Ungheria 5
KZ - Kazakistan 5
PT - Portogallo 5
RS - Serbia 5
UY - Uruguay 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
NO - Norvegia 4
AM - Armenia 3
BY - Bielorussia 3
DM - Dominica 3
JM - Giamaica 3
KW - Kuwait 3
MG - Madagascar 3
MM - Myanmar 3
NZ - Nuova Zelanda 3
OM - Oman 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
CY - Cipro 2
GA - Gabon 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LY - Libia 2
Totale 39.933
Salva come PNG Salva come JPEG
Città #
Singapore 2.386
Southend 2.290
Fairfield 1.856
Ashburn 1.489
Chandler 1.103
Woodbridge 895
Hong Kong 833
Wilmington 794
Seattle 788
Houston 747
Ho Chi Minh City 741
San Jose 681
Dong Ket 676
Santa Clara 628
Hanoi 627
Cambridge 620
Princeton 552
Ann Arbor 474
Jacksonville 401
Beijing 375
Hefei 370
Dublin 355
Boardman 343
Lauterbourg 275
Westminster 251
Dallas 244
Nanjing 238
Los Angeles 226
Padova 218
Tokyo 207
Bologna 197
Helsinki 184
Berlin 183
Lomé 180
Abidjan 169
Munich 156
Buffalo 132
Saint Petersburg 132
Seoul 131
Jinan 123
Da Nang 115
Haiphong 106
Shenyang 106
San Diego 104
Bern 103
Council Bluffs 85
Milan 85
New York 84
Guangzhou 81
Sofia 80
Amman 79
Changsha 76
Delhi 74
Nanchang 74
Frankfurt am Main 71
Hebei 71
Florence 69
Mülheim 68
Dearborn 67
Redondo Beach 66
Des Moines 65
Tianjin 65
Shanghai 60
Turin 56
São Paulo 54
Zhengzhou 53
Chicago 49
Norwalk 47
London 46
Brussels 45
Jiaxing 44
Olalla 41
The Dalles 41
Falls Church 40
Biên Hòa 38
Mahé 38
Hải Dương 37
Medford 37
Abeokuta 36
Phoenix 36
Bengaluru 35
Hangzhou 35
Toronto 35
Johannesburg 34
Verona 34
Yubileyny 34
Bangkok 32
Can Tho 32
Falkenstein 32
Haikou 28
Ningbo 28
Redwood City 28
Baghdad 27
Bremen 25
Taiyuan 25
Ninh Bình 24
Orem 24
Paris 24
Mountain View 23
Fuzhou 22
Totale 26.443
Salva come PNG Salva come JPEG
Nome #
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 335
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 303
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 273
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 269
A new liver transplant priority for patients with hepatocellular carcinoma. 263
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 259
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 257
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 254
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 254
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 249
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 246
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 238
Surgical therapy for hepatolithiasis: a Western experience. 237
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 234
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 233
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 229
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 227
A partnership model between high- And low-volume hospitals to improve results in hepatobiliary pancreatic surgery 227
The peculiar aging of human liver: A geroscience perspective within transplant context 226
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 217
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 213
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 212
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 211
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 208
Coping strategies in intestinal transplantation 208
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 207
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 207
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 207
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 207
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 207
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 205
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 205
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 204
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 204
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 202
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 202
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 201
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 200
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 199
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 198
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 196
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 192
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 192
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 189
Efficacy of MELD score in predicting survival after liver retransplantation. 188
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 188
Iliac Approach for Vascularization of an Intestinal Graft at Retransplantation. 186
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 186
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 184
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 184
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 184
A room for the alpps procedure in patients with HCC 183
Using Elderly Donors in Liver Transplantation. 180
Kidney transplantation combined with other organs in bologna: an update. 179
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 179
Medication compliance after liver transplantation: the importance of family support 178
Comparative pre-and intraoperative imaging evaluation in patients with colorectal liver metastases: A prospective study on 128 resected metastases. 178
ORGAN-SPECIFIC BIOMARKERS OF HUMAN AGING: THE CASE OF LIVER 178
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 177
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 177
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 176
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 176
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 176
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 175
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. 174
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 174
Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. 174
Split-liver transplantation with pediatric donors: a multicenter experience. 173
Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens 173
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 172
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 172
ALPPS for primary and secondary liver tumors 171
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome. 170
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 170
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. 169
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 169
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital. 169
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 169
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 168
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 167
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. 167
Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. 167
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 167
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic Hepatitis C virus infection 167
Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. 167
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. 167
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 167
Model for End-Stage Liver Disease (MELD) System to Allocate and to Share Livers: Experience of Two Italian Centers. 167
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 167
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. 166
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 166
Two years Mycophenolate Mofetil plus low dose calcineurin inhibitor for renal dysfunction after liver transplantation. 165
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. 164
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. 163
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 162
Liver Transplantation With Left Lateral Segments in Adults: A Risk or a Possibility? 162
The role of liver resections for metastases from lung carcinoma. 161
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 161
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 161
The Immune Landscape of Cancer 161
Totale 19.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.531 0 0 0 0 0 0 0 0 0 196 176 1.159
2021/20224.519 445 183 348 399 413 247 100 307 135 244 931 767
2022/20234.845 526 754 253 633 264 340 141 317 848 132 402 235
2023/20241.081 93 248 73 110 79 161 47 74 28 74 44 50
2024/20255.361 183 889 450 423 971 317 322 128 91 378 149 1.060
2025/202611.720 1.108 1.085 1.277 923 1.346 904 1.257 480 2.552 788 0 0
Totale 40.559